Importer of Controlled Substances Application: Cerilliant Corporation, 48506-48509 [2022-16994]

Download as PDF 48506 Federal Register / Vol. 87, No. 152 / Tuesday, August 9, 2022 / Notices Controlled substance Norfentanyl ..................................................................................................................................................................................... Phenylacetone ................................................................................................................................................................................ 1-Piperidinocyclohexanecarbonitrile ............................................................................................................................................... Alphaprodine .................................................................................................................................................................................. Cocaine .......................................................................................................................................................................................... Codeine .......................................................................................................................................................................................... Dihydrocodeine ............................................................................................................................................................................... Oxycodone ..................................................................................................................................................................................... Hydromorphone .............................................................................................................................................................................. Diphenoxylate ................................................................................................................................................................................. Ecgonine ......................................................................................................................................................................................... Ethylmorphine ................................................................................................................................................................................. Hydrocodone .................................................................................................................................................................................. Levomethorphan ............................................................................................................................................................................. Levorphanol .................................................................................................................................................................................... Isomethadone ................................................................................................................................................................................. Meperidine ...................................................................................................................................................................................... Meperidine intermediate-A ............................................................................................................................................................. Meperidine intermediate-B ............................................................................................................................................................. Meperidine intermediate-C ............................................................................................................................................................. Metazocine ..................................................................................................................................................................................... Methadone ...................................................................................................................................................................................... Methadone intermediate ................................................................................................................................................................. Dextropropoxyphene, bulk (non-dosage forms) ............................................................................................................................. Morphine ......................................................................................................................................................................................... Thebaine ......................................................................................................................................................................................... Levo-alphacetylmethadol ................................................................................................................................................................ Oxymorphone ................................................................................................................................................................................. Noroxymorphone ............................................................................................................................................................................ Thiafentanil ..................................................................................................................................................................................... Racemethorphan ............................................................................................................................................................................ Alfentanil ......................................................................................................................................................................................... Remifentanil .................................................................................................................................................................................... Sufentanil ........................................................................................................................................................................................ Carfentanil ...................................................................................................................................................................................... Tapentadol ...................................................................................................................................................................................... Fentanyl .......................................................................................................................................................................................... The company plans to bulk manufacture the listed controlled substances for the internal use intermediates or for sale to its customers. In reference to dug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. Kristi O’Malley, Assistant Administrator. [FR Doc. 2022–17006 Filed 8–8–22; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration jspears on DSK121TN23PROD with NOTICES [Docket No. DEA–1052] Importer of Controlled Substances Application: Cerilliant Corporation Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: VerDate Sep<11>2014 18:04 Aug 08, 2022 Jkt 256001 Cerilliant Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before September 8, 2022. Such persons may also file a written request for a hearing on the application on or before September 8, 2022. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be SUMMARY: PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 Drug code Schedule 8366 8501 8603 9010 9041 9050 9120 9143 9150 9170 9180 9190 9193 9210 9220 9226 9230 9232 9233 9234 9240 9250 9254 9273 9300 9333 9648 9652 9668 9729 9732 9737 9739 9740 9743 9780 9801 II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. In accordance with 21 CFR 1301.34(a), this is notice that on June 30, 2022, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665–2402, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: E:\FR\FM\09AUN1.SGM 09AUN1 48507 Federal Register / Vol. 87, No. 152 / Tuesday, August 9, 2022 / Notices jspears on DSK121TN23PROD with NOTICES Controlled substance 3-Fluoro-N-methylcathinone (3–FMC) ............................................................................................................................................ Cathinone ....................................................................................................................................................................................... Methcathinone ................................................................................................................................................................................ 4-Fluoro-N-methylcathinone (4–FMC) ............................................................................................................................................ Pentedrone (a-methylaminovalerophenone) .................................................................................................................................. Mephedrone (4-Methyl-N-methylcathinone) ................................................................................................................................... 4-Methyl-N-ethylcathinone (4–MEC) .............................................................................................................................................. Naphyrone ...................................................................................................................................................................................... N-Ethylamphetamine ...................................................................................................................................................................... N,N-Dimethylamphetamine ............................................................................................................................................................ Fenethylline .................................................................................................................................................................................... Methaqualone ................................................................................................................................................................................. JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ................................................................................................................. SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ............................................................... 5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ............................... AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .................................... JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ..................................................................................................................................... AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ........................................................ THJ–2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ................................................................................ AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) .............................. ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................................ APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ........................................................................... JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ................................................................................................................. SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) .................................................................................. JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ............................................................................................. JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) .................................................................................................................... UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ................................................................................ JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ...................................................................................................................................... JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ......................................................................................................... AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ...................................................................................................................... JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ..................................................................................................................... PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ................................................................................................................ 5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ........................................................................................... Alpha-ethyltryptamine ..................................................................................................................................................................... Ibogaine .......................................................................................................................................................................................... CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ............................................................................... CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ......................................................... Lysergic acid diethylamide ............................................................................................................................................................. 2C–T–7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine .............................................................................................................. Marihuana ....................................................................................................................................................................................... Parahexyl ........................................................................................................................................................................................ Mescaline ....................................................................................................................................................................................... 2C–T–2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine ) ......................................................................................................... 3,4,5-Trimethoxyamphetamine ....................................................................................................................................................... 4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................................ 4-Bromo-2,5-dimethoxyphenethylamine ......................................................................................................................................... 4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................................ 2,5-Dimethoxyamphetamine ........................................................................................................................................................... JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ..................................................................................................................... 3,4-Methylenedioxyamphetamine ................................................................................................................................................... 5-Methoxy-3,4-methylenedioxyamphetamine ................................................................................................................................. N-Hydroxy-3,4-methylenedioxyamphetamine ................................................................................................................................. 3,4-Methylenedioxy-N-ethylamphetamine ...................................................................................................................................... 3,4-Methylenedioxymethamphetamine ........................................................................................................................................... 4-Methoxyamphetamine ................................................................................................................................................................. 5-Methoxy-N-N-dimethyltryptamine ................................................................................................................................................ Alpha-methyltryptamine .................................................................................................................................................................. Bufotenine ...................................................................................................................................................................................... Diethyltryptamine ............................................................................................................................................................................ Dimethyltryptamine ......................................................................................................................................................................... Psilocybin ....................................................................................................................................................................................... Psilocyn .......................................................................................................................................................................................... 5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................................ N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................................. 1-(1-Phenylcyclohexyl)pyrrolidine ................................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]piperidine .............................................................................................................................................. N-Benzylpiperazine ........................................................................................................................................................................ 4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) .................................................................................................................... 2C–D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) ................................................................................................................. 2C–E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) .................................................................................................................... 2C–H 2-(2,5-Dimethoxyphenyl) ethanamine) ................................................................................................................................. 2C–I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ........................................................................................................................ 2C–C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) .................................................................................................................. VerDate Sep<11>2014 18:04 Aug 08, 2022 Jkt 256001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\09AUN1.SGM 09AUN1 Drug code Schedule 1233 1235 1237 1238 1246 1248 1249 1258 1475 1480 1503 2565 6250 7008 7011 7012 7019 7023 7024 7031 7035 7048 7081 7104 7118 7122 7144 7173 7200 7201 7203 7222 7225 7249 7260 7297 7298 7315 7348 7360 7374 7381 7385 7390 7391 7392 7395 7396 7398 7400 7401 7402 7404 7405 7411 7431 7432 7433 7434 7435 7437 7438 7439 7455 7458 7470 7493 7498 7508 7509 7517 7518 7519 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 48508 Federal Register / Vol. 87, No. 152 / Tuesday, August 9, 2022 / Notices jspears on DSK121TN23PROD with NOTICES Controlled substance 2C–N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ................................................................................................................... 2C–P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) ............................................................................................................ 2C–T–4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ................................................................................................... MDPV (3,4-Methylenedioxypyrovalerone) ...................................................................................................................................... 25B–NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ................................................................... 25C–NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ................................................................... 25I–NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ........................................................................ Methylone (3,4-Methylenedioxy-N-methylcathinone) ..................................................................................................................... Butylone .......................................................................................................................................................................................... Pentylone ........................................................................................................................................................................................ alpha-pyrrolidinopentiophenone (a-PVP) ....................................................................................................................................... alpha-pyrrolidinobutiophenone (a-PBP) ......................................................................................................................................... AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) .................................................................................................................. Desomorphine ................................................................................................................................................................................ Etorphine (except HCl) ................................................................................................................................................................... Codeine methylbromide ................................................................................................................................................................. Heroin ............................................................................................................................................................................................. Morphine-N-oxide ........................................................................................................................................................................... Normorphine ................................................................................................................................................................................... Pholcodine ...................................................................................................................................................................................... U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ............................................................................. AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ................................................................................. Acetylmethadol ............................................................................................................................................................................... Allylprodine ..................................................................................................................................................................................... Alphacetylmethadol except levo-alphacetylmethadol .................................................................................................................... Alphameprodine ............................................................................................................................................................................. Alphamethadol ................................................................................................................................................................................ Betacetylmethadol .......................................................................................................................................................................... Betameprodine ............................................................................................................................................................................... Betamethadol ................................................................................................................................................................................. Betaprodine .................................................................................................................................................................................... Dextromoramide ............................................................................................................................................................................. Dipipanone ..................................................................................................................................................................................... Hydroxypethidine ............................................................................................................................................................................ Noracymethadol ............................................................................................................................................................................. Norlevorphanol ............................................................................................................................................................................... Normethadone ................................................................................................................................................................................ Racemoramide ............................................................................................................................................................................... Trimeperidine .................................................................................................................................................................................. 1-Methyl-4-phenyl-4-propionoxypiperidine ..................................................................................................................................... Tilidine ............................................................................................................................................................................................ Para-Fluorofentanyl ........................................................................................................................................................................ 3-Methylfentanyl ............................................................................................................................................................................. Alpha-methylfentanyl ...................................................................................................................................................................... Acetyl-alpha-methylfentanyl ........................................................................................................................................................... Beta-hydroxyfentanyl ...................................................................................................................................................................... Beta-hydroxy-3-methylfentanyl ....................................................................................................................................................... Alpha-methylthiofentanyl ................................................................................................................................................................ 3-Methylthiofentanyl ....................................................................................................................................................................... Thiofentanyl .................................................................................................................................................................................... Fentanyl related-compounds as defined in 21 CFR 1308.11(h) .................................................................................................... Methamphetamine .......................................................................................................................................................................... Methylphenidate ............................................................................................................................................................................. Amobarbital .................................................................................................................................................................................... Pentobarbital .................................................................................................................................................................................. Secobarbital .................................................................................................................................................................................... Glutethimide ................................................................................................................................................................................... Nabilone ......................................................................................................................................................................................... 1-Phenylcyclohexylamine ............................................................................................................................................................... Phencyclidine ................................................................................................................................................................................. Phenylacetone ................................................................................................................................................................................ 1-Piperidinocyclohexanecarbonitrile ............................................................................................................................................... Alphaprodine .................................................................................................................................................................................. Dihydrocodeine ............................................................................................................................................................................... Ecgonine ......................................................................................................................................................................................... Ethylmorphine ................................................................................................................................................................................. Levomethorphan ............................................................................................................................................................................. Levorphanol .................................................................................................................................................................................... Meperidine ...................................................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) ............................................................................................................................. Levo-alphacetylmethadol ................................................................................................................................................................ Noroxymorphone ............................................................................................................................................................................ Racemethorphan ............................................................................................................................................................................ VerDate Sep<11>2014 18:04 Aug 08, 2022 Jkt 256001 PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 E:\FR\FM\09AUN1.SGM 09AUN1 Drug code Schedule 7521 7524 7532 7535 7536 7537 7538 7540 7541 7542 7545 7546 7694 9055 9056 9070 9200 9307 9313 9314 9547 9551 9601 9602 9603 9604 9605 9607 9608 9609 9611 9613 9622 9627 9633 9634 9635 9645 9646 9661 9750 9812 9813 9814 9815 9830 9831 9832 9833 9835 9850 1105 1724 2125 2270 2315 2550 7379 7460 7471 8501 8603 9010 9120 9180 9190 9210 9220 9230 9273 9648 9668 9732 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II II II II 48509 Federal Register / Vol. 87, No. 152 / Tuesday, August 9, 2022 / Notices Controlled substance Alfentanil ......................................................................................................................................................................................... Remifentanil .................................................................................................................................................................................... Sufentanil ........................................................................................................................................................................................ Carfentanil ...................................................................................................................................................................................... Tapentadol ...................................................................................................................................................................................... The company plans to import the listed controlled substances for the manufacturing of analytical reference standards and distribution to their research and forensic customers. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Kristi O’Malley, Assistant Administrator. [FR Doc. 2022–16994 Filed 8–8–22; 8:45 am] BILLING CODE P the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on July 7, 2022, Experic LLC, 2 Clarke Drive, Cranbury, New Jersey 08512–3619, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): Controlled substance DEPARTMENT OF JUSTICE Psilocybin ........................ Psilocyn ........................... Drug code Schedule 7437 7438 I I Drug Enforcement Administration [Docket No. DEA–1064] Bulk Manufacturer of Controlled Substances Application: Experic LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Experic LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before October 11, 2022. Such persons may also file a written request for a hearing on the application on or before October 11, 2022. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow jspears on DSK121TN23PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:04 Aug 08, 2022 Jkt 256001 The company plans to bulk manufacture the listed controlled substances for drug codes 7437 (Psilocybin) and 7438 (Psilocyn), planning on germinating mushrooms to be harvested and freeze dried in form of powder to be filled into capsules for use in clinical studies. Kristi O’Malley, Assistant Administrator. [FR Doc. 2022–17012 Filed 8–8–22; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1042] Importer of Controlled Substances Application: Sharp Clinical Services, LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Frm 00059 Fmt 4703 Sfmt 4703 9737 9739 9740 9743 9780 II II II II II Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before September 8, 2022. Such persons may also file a written request for a hearing on the application on or before September 8, 2022. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on May 23, 2022, Sharp Clinical Services, LLC, 2400 Baglyos Circle, Bethlehem, Pennsylvania 18020– 8024, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUMMARY: PO 00000 Schedule DATES: Controlled substance Sharp Clinical Services, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. Drug code 5-Methoxy-N-Ndimethyltryptamine. Drug code 7431 Schedule I The company plans to import the listed control substances for clinical E:\FR\FM\09AUN1.SGM 09AUN1

Agencies

[Federal Register Volume 87, Number 152 (Tuesday, August 9, 2022)]
[Notices]
[Pages 48506-48509]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-16994]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1052]


Importer of Controlled Substances Application: Cerilliant 
Corporation

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Cerilliant Corporation has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
September 8, 2022. Such persons may also file a written request for a 
hearing on the application on or before September 8, 2022.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment. All 
requests for a hearing must be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. All requests for a hearing should also be 
sent to: Drug Enforcement Administration, Attn: Administrator, 8701 
Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on June 30, 2022, Cerilliant Corporation, 811 Paloma 
Drive, Suite A, Round Rock, Texas 78665-2402, applied to be registered 
as an importer of the following basic class(es) of controlled 
substance(s):

[[Page 48507]]



------------------------------------------------------------------------
                                                 Drug
             Controlled substance                code       Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC)............    1233  I
Cathinone.....................................    1235  I
Methcathinone.................................    1237  I
4-Fluoro-N-methylcathinone (4-FMC)............    1238  I
Pentedrone ([alpha]-methylaminovalerophenone).    1246  I
Mephedrone (4-Methyl-N-methylcathinone).......    1248  I
4-Methyl-N-ethylcathinone (4-MEC).............    1249  I
Naphyrone.....................................    1258  I
N-Ethylamphetamine............................    1475  I
N,N-Dimethylamphetamine.......................    1480  I
Fenethylline..................................    1503  I
Methaqualone..................................    2565  I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)       6250  I
 indole).
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-   7008  I
 3-(2-methoxyphenylacetyl) indole).
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-           7011  I
 pentyl)1H-indol-3-yl](2,2,3,3-
 tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-    7012  I
 yl)-1-(4-fluorobenzyl)-1H-indazole-3-
 carboxamide).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).......    7019  I
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-      7023  I
 yl)-1-pentyl-1H-indazole-3-carboxamide).
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-       7024  I
 yl](naphthalen-1-yl)methanone).
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-    7031  I
 yl)-1-(cyclohexylmethyl)-1H-indazole-3-
 carboxamide).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-   7035  I
 2-yl)-1-pentyl-1H-indazole-3-carboxamide).
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-   7048  I
 indazole-3-carboxamide).
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl)       7081  I
 indole).
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-      7104  I
 methoxy)-benzoyl] indole).
JWH-018 (also known as AM678) (1-Pentyl-3-(1-     7118  I
 naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)        7122  I
 indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-          7144  I
 tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-naphthoyl)indole).......    7173  I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-         7200  I
 naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)        7201  I
 indole).
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)        7203  I
 indole).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-        7222  I
 carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-    7225  I
 indole-3-carboxylate).
Alpha-ethyltryptamine.........................    7249  I
Ibogaine......................................    7260  I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-   7297  I
 hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-    7298  I
 2-[(1R,3S)3-hydroxycyclohexyl-phenol).
Lysergic acid diethylamide....................    7315  I
2C-T-7 (2,5-Dimethoxy-4-(n)-                      7348  I
 propylthiophenethylamine.
Marihuana.....................................    7360  I
Parahexyl.....................................    7374  I
Mescaline.....................................    7381  I
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl)       7385  I
 ethanamine ).
3,4,5-Trimethoxyamphetamine...................    7390  I
4-Bromo-2,5-dimethoxyamphetamine..............    7391  I
4-Bromo-2,5-dimethoxyphenethylamine...........    7392  I
4-Methyl-2,5-dimethoxyamphetamine.............    7395  I
2,5-Dimethoxyamphetamine......................    7396  I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)        7398  I
 indole).
3,4-Methylenedioxyamphetamine.................    7400  I
5-Methoxy-3,4-methylenedioxyamphetamine.......    7401  I
N-Hydroxy-3,4-methylenedioxyamphetamine.......    7402  I
3,4-Methylenedioxy-N-ethylamphetamine.........    7404  I
3,4-Methylenedioxymethamphetamine.............    7405  I
4-Methoxyamphetamine..........................    7411  I
5-Methoxy-N-N-dimethyltryptamine..............    7431  I
Alpha-methyltryptamine........................    7432  I
Bufotenine....................................    7433  I
Diethyltryptamine.............................    7434  I
Dimethyltryptamine............................    7435  I
Psilocybin....................................    7437  I
Psilocyn......................................    7438  I
5-Methoxy-N,N-diisopropyltryptamine...........    7439  I
N-Ethyl-1-phenylcyclohexylamine...............    7455  I
1-(1-Phenylcyclohexyl)pyrrolidine.............    7458  I
1-[1-(2-Thienyl)cyclohexyl]piperidine.........    7470  I
N-Benzylpiperazine............................    7493  I
4-MePPP (4-Methyl-                                7498  I
 alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4-methylphenyl)            7508  I
 ethanamine).
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl)             7509  I
 ethanamine).
2C-H 2-(2,5-Dimethoxyphenyl) ethanamine)......    7517  I
2C-I 2-(4-iodo-2,5-dimethoxyphenyl)               7518  I
 ethanamine).
2C-C 2-(4-Chloro-2,5-dimethoxyphenyl)             7519  I
 ethanamine).

[[Page 48508]]

 
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl)            7521  I
 ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl)        7524  I
 ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5-                  7532  I
 dimethoxyphenyl) ethanamine).
MDPV (3,4-Methylenedioxypyrovalerone).........    7535  I
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-     7536  I
 (2-methoxybenzyl) ethanamine).
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-    7537  I
 (2-methoxybenzyl) ethanamine).
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-   7538  I
 methoxybenzyl) ethanamine).
Methylone (3,4-Methylenedioxy-N-                  7540  I
 methylcathinone).
Butylone......................................    7541  I
Pentylone.....................................    7542  I
alpha-pyrrolidinopentiophenone ([alpha]-PVP)..    7545  I
alpha-pyrrolidinobutiophenone ([alpha]-PBP)...    7546  I
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)      7694  I
 indole).
Desomorphine..................................    9055  I
Etorphine (except HCl)........................    9056  I
Codeine methylbromide.........................    9070  I
Heroin........................................    9200  I
Morphine-N-oxide..............................    9307  I
Normorphine...................................    9313  I
Pholcodine....................................    9314  I
U-47700 (3,4-dichloro-N-[2-                       9547  I
 (dimethylamino)cyclohexyl]-N-methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1-                      9551  I
 dimethylamino)cyclohexylmethyl]benzamide)).
Acetylmethadol................................    9601  I
Allylprodine..................................    9602  I
Alphacetylmethadol except levo-                   9603  I
 alphacetylmethadol.
Alphameprodine................................    9604  I
Alphamethadol.................................    9605  I
Betacetylmethadol.............................    9607  I
Betameprodine.................................    9608  I
Betamethadol..................................    9609  I
Betaprodine...................................    9611  I
Dextromoramide................................    9613  I
Dipipanone....................................    9622  I
Hydroxypethidine..............................    9627  I
Noracymethadol................................    9633  I
Norlevorphanol................................    9634  I
Normethadone..................................    9635  I
Racemoramide..................................    9645  I
Trimeperidine.................................    9646  I
1-Methyl-4-phenyl-4-propionoxypiperidine......    9661  I
Tilidine......................................    9750  I
Para-Fluorofentanyl...........................    9812  I
3-Methylfentanyl..............................    9813  I
Alpha-methylfentanyl..........................    9814  I
Acetyl-alpha-methylfentanyl...................    9815  I
Beta-hydroxyfentanyl..........................    9830  I
Beta-hydroxy-3-methylfentanyl.................    9831  I
Alpha-methylthiofentanyl......................    9832  I
3-Methylthiofentanyl..........................    9833  I
Thiofentanyl..................................    9835  I
Fentanyl related-compounds as defined in 21       9850  I
 CFR 1308.11(h).
Methamphetamine...............................    1105  II
Methylphenidate...............................    1724  II
Amobarbital...................................    2125  II
Pentobarbital.................................    2270  II
Secobarbital..................................    2315  II
Glutethimide..................................    2550  II
Nabilone......................................    7379  II
1-Phenylcyclohexylamine.......................    7460  II
Phencyclidine.................................    7471  II
Phenylacetone.................................    8501  II
1-Piperidinocyclohexanecarbonitrile...........    8603  II
Alphaprodine..................................    9010  II
Dihydrocodeine................................    9120  II
Ecgonine......................................    9180  II
Ethylmorphine.................................    9190  II
Levomethorphan................................    9210  II
Levorphanol...................................    9220  II
Meperidine....................................    9230  II
Dextropropoxyphene, bulk (non-dosage forms)...    9273  II
Levo-alphacetylmethadol.......................    9648  II
Noroxymorphone................................    9668  II
Racemethorphan................................    9732  II

[[Page 48509]]

 
Alfentanil....................................    9737  II
Remifentanil..................................    9739  II
Sufentanil....................................    9740  II
Carfentanil...................................    9743  II
Tapentadol....................................    9780  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
the manufacturing of analytical reference standards and distribution to 
their research and forensic customers. No other activities for these 
drug codes are authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-16994 Filed 8-8-22; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.